Rupert D’Souza
Geen lopende functies
Vermogen: 70 205 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Rupert D’Souza
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 9 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Rupert D’Souza via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BECTON, DICKINSON AND COMPANY | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| MERRIMAN HOLDINGS, INC. | Investment Banks/Brokers | Director of Finance/CFO | |
Signature BioScience, Inc.
 Signature BioScience, Inc. Miscellaneous Commercial ServicesCommercial Services Signature BioScience, Inc. discovers new drugs by applying its parallel target and compound selection process. The private company is based in Hayward, CA and has subsidiaries in the United States. The company was founded by Andrew Peter Sandham and John Hefti. | Miscellaneous Commercial Services | Chief Administrative Officer | |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Lux Biosciences, Inc.
 Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| OCULAR THERAPEUTIX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| UNILIFE CORP | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Russell Reynolds Associates, Inc.
 Russell Reynolds Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Russell Reynolds Associates, Inc. provides executive recruitment services. Its services include chief executive officer and board advisory services, culture assessment, executive search, global supply chain and leadership assessment. The company was founded in 1969 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Sales & Marketing | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Booz Allen Hamilton, Inc.
 Booz Allen Hamilton, Inc. Engineering & ConstructionIndustrial Services Booz Allen Hamilton, Inc. engages in the provision of management and technology consulting services. Its services include consulting, analytics, digital solutions, engineering, cyber security, and product. The company was founded by Edwin G. Booz in 1914 and is headquartered in McLean, VA. | Engineering & Construction | Corporate Officer/Principal | |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Florida Atlantic University | College/University | Undergraduate Degree | |
| Harvey Mudd College | College/University | Undergraduate Degree | |
| Nova Southeastern University, Inc. | College/University | Doctorate Degree | |
| University of Michigan | College/University | Doctorate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree | |
| Wellesley College | College/University | Undergraduate Degree | |
National Veterinary Associates, Inc.
 National Veterinary Associates, Inc. Agricultural Commodities/MillingProcess Industries National Veterinary Associates, Inc. engages in the ownership and operation of animal veterinary hospitals. It supports local medical standards as established by individual hospitals and practitioners. The firm provides emerging research and care standards, access to its national medical database, human resource guidance, marketing support, recruiting assistance, tax preparation and training and education for staff. The company was founded by Stanley R. Creighton in 1996 and is headquartered in Agoura Hills, CA. | Agricultural Commodities/Milling | Human Resources Officer | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
| New York Medical College | College/University | Corporate Officer/Principal | |
| Université Claude Bernard Lyon 1 | College/University | Doctorate Degree | |
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
| Hacettepe University | College/University | Doctorate Degree | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Biotechnology | Corporate Officer/Principal | |
| CLEARSIDE BIOMEDICAL, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PLIANT THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Sunbit, Inc.
 Sunbit, Inc. Information Technology ServicesTechnology Services Sunbit, Inc. builds payment method of the future. Its method Sunbit is the way for retailers to split a purchase into multiple payments, increasing sales and extending the buying power of customers so that retailers to earn more while customers pay less. The company was founded by Arad Levertov, Ornit Dweck-Maizel and Tal Riesenfeld in 2016 and is headquartered in Beverly Hills, CA. | Information Technology Services | Human Resources Officer | |
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Biotechnology | Chief Operating Officer | |
| NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| AKOUOS | Biotechnology | Corporate Officer/Principal | |
| Clinvec Solutions LLC | Miscellaneous | Corporate Officer/Principal | |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Chairman | |
Bright Peak Therapeutics, Inc.
 Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The private company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | Pharmaceuticals: Major | Director/Board Member | |
| Okarios AG | Chief Operating Officer | ||
Santa Ana Bio, Inc.
 Santa Ana Bio, Inc. BiotechnologyHealth Technology Santa Ana Bio, Inc. is a biotechnology company that specializes in precision immunology for autoimmune diseases. The company is based in Alameda, CA. The CEO of the company is Peter Emtage. | Biotechnology | Director/Board Member | |
| TEMPEST THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 40 |
| Zwitserland | 5 |
| Verenigd Koninkrijk | 4 |
| Frankrijk | 4 |
| Turkije | 2 |
Sectoraal
| Health Technology | 32 |
| Consumer Services | 11 |
| Finance | 3 |
| Commercial Services | 3 |
| Industrial Services | 2 |
Operationeel
| Director/Board Member | 29 |
| Corporate Officer/Principal | 27 |
| Chief Tech/Sci/R&D Officer | 17 |
| Director of Finance/CFO | 9 |
| Independent Dir/Board Member | 9 |
Sterkste connecties
| Insiders | |
|---|---|
| Thomas Woiwode | 39 |
| Richard Beckman | 12 |
| Jack Anthony Thrift | 11 |
| Rabia Ozden | 9 |
| Mehdi Gasmi | 8 |
| Soo Hong | 8 |
| Star Seyedkazemi | 7 |
| Nancy E. Pecota | 6 |
| Jon Williams | 4 |
- Beurs
- Insiders
- Rupert D’Souza
- Bedrijfsconnecties
